Join us for the
FA Research Flash Talk Series
This year, in honor of FA Awareness month, FARA is proud to present: The FA Research Flash Talks series - featuring Young Investigators from FARA funded laboratories around the world. This four-part series will cover key aspects of FARA funded research from gene silencing and disease mechanisms to therapeutic avenues and clinical insights. Each session will include Flash Talks from four to five Young Investigators (ie, postdocs and graduate students). Each Flash Talk will be limited to a maximum of five minutes and a single PowerPoint slide and will be suitable for a lay audience. We will also allott time for a brief Q&A following the talks.

Click the button below to register for one, two, three, or all four of the sessions. You will have the option to select which sessions you wish to attend.
Session #1
May 6, 2021 - 7pm EDT
Investigating epigenetic silencing in Friedreich's Ataxia
Rucha Dilip Sarwade, Monash University

Antisense oligonucleotides targeting FXN intron 1 can activate FXN expression
Feng Damon Wang, UMass Medical School

NAD+ and Exercise in Friedreich's Ataxia
Jaclyn Tamaroff, Children's Hospital of Philadelphia

Brain white matter pathways in FA
Louisa Selvadurai, Monash University
Session #2
May 13, 2021 - 12pm EDT
Visceral white adipose tissue as a possible therapeutic target to prevent type 2 diabetes development in Friedreich’s ataxia
Riccardo Turchi, University of Tor vergata, Rome

An in vitro Model System for the Study of Proprioceptor Vulnerability in Friedreich's Ataxia
Chiara Dionisi, Université Libre de Bruxelles

Transplantation of CRISPR/Cas9 Corrected Hematopoietic Stem and Progenitor Cells into a Mouse Model of Friedreich's Ataxia
Joseph N Rainaldi, University of California, San Diego

White Matter Damage Staging Schema in Friedreich Ataxia
Thiago JR Rezende, University of Campinas

IDEA Study: Searching For a Better Way to Measure Ataxia
Hannah Casey, The University of Chicago
Session #3
May 20, 2021 - 7pm EDT
Molecular defects in Friedreich's Ataxia - pathophysiological cytoskeletal abnormalities
Frances M Smith, University at Buffalo

Friedreich's ataxia neuronal progenitor cells (NPCs) containing an endogenous FXN-luciferase fusion gene as a novel screening platform
Anna Maria Schreiber, University of Alabama at Birmingham

Sugar-based nanoparticles for frataxin delivery
Ewa Czuba-Wojnilowicz, The University of Melbourne

Spinal cord diffusion tensor imaging in Friedreich’s ataxia
Ana Luisa de Carvalho Cardozo Hernández, University of Campinas

Bone Health in Friedreich's Ataxia
Julia Dunn, Children's Hospital of Philadelphia
Session #4
May 27, 2021 - 12pm EDT
Cytoskeletal filament proteins in Friedreich cardiomyopathy
Rahman F Rafique, Albany Research Institute

Application of genome editing technologies in potential therapeutics of Friedreich ataxia
Zaneta Matuszek, Harvard University/the Broad Institute

Pre-clinical left ventricular myocardial remodeling in patients with Friedreich’s ataxia: A cardiac MRI study
Karen Girotto, University of Campinas

The Friedreich's ataxia Health Indices (FA-HI): Novel Outcomes for Measuring How a Patient Feels and Functions in Clinical Trials
Jamison Seabury, University of Rochester Center for Health + Technology